16:50 IST
BSE
Board Meeting Outcome
Bacil Pharma Board Meeting Outcome
Bacil Pharma Limited announced the appointment of Mr. Mahesh Singh and Mr. Anil Shiv Charan Singh as Additional Directors following its board meeting.
Bacil Pharma Ltd
- Share price
- ₹25.50
- Market cap
- ₹36.60 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹1.56 Cr
- P/E (TTM)
- 55.8×Sector 47.4×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 5Board Meeting Date 5Fund Raise 3Financial Results 3Merger & Restructuring 2Board Meeting Outcome 2Management Change 1Capital Structure Change 1Annual Report 1Annual General Meeting 1
Time
2 announcements with these filters
15:24 IST
BSE
Board Meeting Outcome
Bacil Pharma Board Meeting Outcome
Bacil Pharma Ltd’s board approved a ₹50 Crore rights issue and increased authorized capital by ₹45 Crore. It also accepted the resignations of two independent directors.
- Value
- ₹50.00 Cr